Effect of Therapy on Survival in Angina Pectoris.

Abstract

s1 May 1968Effect of Therapy on Survival in Angina Pectoris.Ezra A. Amsterdam, M.D., Steven Wolfson, M.D., Richard Gorlin, M.D., F.A.C.P.Ezra A. Amsterdam, M.D.Search for more papers by this author, Steven Wolfson, M.D.Search for more papers by this author, Richard Gorlin, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-68-5-1151_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe prognosis of patients treated with either propranolol, internal mammary artery implantation (IMI), or conventional therapy for angina pectoris was compared. Forty-three patients were treated with propanolol and 49 with IMI. Forty-six received only standard medical therapy and served as a control group. All subjects had coronary artery disease documented by coronary arteriography. The average duration of observation for the entire series was 18 months. No significant differences between the two treated and the control groups were noted with respect to the following factors: age, sex, duration of coronary artery disease, presence of previous myocardial infarct, hypertension, diabetes mellitus, increased... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: Ezra A. Amsterdam, M.D.; Steven Wolfson, M.D.; Richard Gorlin, M.D., F.A.C.P.Affiliations: Boston, Massachusetts PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byThe Value of Treatment in the Prevention of Hypertension ComplicationsThe natural history of coronary artery disease: Does medical therapy improve the prognosis?Pharmacologic Approaches to the Prevention of Myocardial Infarction and Sudden DeathTreatment of Angina Pectoris in General Practice with a Combination of Nifedipine and Beta‐B lockerThe Influence of Previous Physical Activity on Survival and Reinfarction after First Myocardial InfarctionSecondary Prevention Trials with β-Blocking Drugs After Myocardial InfarctionBETA BLOCKERS AFTER MYOCARDIAL INFARCTION - ASPECTS ON STUDY DESIGN BASED ON CURRENT KNOWLEDGEChronic Beta Blockade after Myocardial InfarctionClinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction:the continuing controversyLong-Term Intervention with Beta-Blocking Agents in Ischemic Heart DiseaseMyocardial Metabolism in Angina PectorisThe effect of γ-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular diseaseImprovement in prognosis of myocardial infarction by long-term beta-adrenoceptor blockadeLong-term treatment with ?-blockers after myocardial infarctionDEATHS AND NON-FATAL REINFARCTIONS DURING TWO YEARS‘ FOLLOW-UPREDUCTION OF SUDDEN DEATHS AFTER MYOCARDIAL INFARCTION BY TREATMENT WITH ALPRENOLOLPERMEABILITY OF AORTIC ENDOTHELIUMBETA-BLOCKERS AND LIFE EXPECTANCY IN ISCHÆMIC HEART-DISEASEβ-ReceptorenblockerChapter 8. Antianginal DrugsBeta-adrenergic blocking agents for the treatment of angina pectoris 1 May 1968Volume 68, Issue 5 Page: 1151-1151 Keywords Angina Angiography Arteries Coronary arteries Diabetes mellitus Hypertension Myocardial infarction Stable coronary artery disease ePublished: 1 December 2008 Issue Published: 1 May 1968 PDF downloadLoading ...